Medpace Holdings Change in Inventories 2014-2025 | MEDP
Medpace Holdings annual/quarterly change in inventories history and growth rate from 2014 to 2025. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.
- Medpace Holdings change in inventories for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
- Medpace Holdings change in inventories for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
- Medpace Holdings annual change in inventories for 2024 was $0B, a 0% decline from 2023.
- Medpace Holdings annual change in inventories for 2023 was $0B, a 0% decline from 2022.
- Medpace Holdings annual change in inventories for 2022 was $0B, a 0% decline from 2021.
| Medpace Holdings Annual Change in Inventories (Millions of US $) |
|
|---|---|
| 2024 | $N/A |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| 2018 | $N/A |
| 2017 | $N/A |
| 2016 | $N/A |
| 2015 | $N/A |
| 2014 | $N/A |
| 2013 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.635B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.038B | 26.53 |
| CVS Health (CVS) | United States | $82.289B | 10.23 |
| Elevance Health (ELV) | United States | $65.480B | 8.81 |
| Cencora (COR) | United States | $56.344B | 18.77 |
| DiDi Global (DIDIY) | China | $25.603B | 27.20 |
| Labcorp Holdings (LH) | United States | $22.243B | 17.68 |
| Natera (NTRA) | United States | $21.553B | 0.00 |
| BioMerieux (BMXMF) | France | $17.652B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.635B | 0.00 |
| CochLear (CHEOY) | Australia | $13.465B | 0.00 |
| ICON (ICLR) | Ireland | $12.898B | 12.41 |
| Solventum (SOLV) | United States | $12.460B | 12.85 |
| Viatris (VTRS) | United States | $11.496B | 4.09 |
| Revvity (RVTY) | United States | $9.959B | 17.55 |
| Sonic Healthcare (SKHHY) | Australia | $8.980B | 0.00 |
| Avantor (AVTR) | United States | $8.249B | 12.10 |
| HealthEquity (HQY) | United States | $7.996B | 35.02 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.329B | 13.91 |
| Bausch + Lomb (BLCO) | Canada | $4.825B | 32.45 |
| Sotera Health (SHC) | United States | $3.994B | 22.32 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.660B | 27.92 |
| GeneDx Holdings (WGS) | United States | $3.175B | 72.72 |
| Surgery Partners (SGRY) | United States | $2.915B | 36.68 |
| Alignment Healthcare (ALHC) | United States | $2.893B | 0.00 |
| Concentras Parent (CON) | United States | $2.753B | 17.46 |
| Organon (OGN) | United States | $2.342B | 2.55 |
| Premier (PINC) | United States | $1.922B | 14.59 |
| Progyny (PGNY) | United States | $1.870B | 39.54 |
| PACS (PACS) | United States | $1.731B | 0.00 |
| Ardent Health (ARDT) | United States | $1.723B | 6.65 |
| GoodRx Holdings (GDRX) | United States | $1.243B | 20.47 |
| Pediatrix Medical (MD) | United States | $1.230B | 8.21 |
| Teladoc Health (TDOC) | United States | $1.198B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.974B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Embecta (EMBC) | United States | $0.745B | 4.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.632B | 7.82 |
| CareDx (CDNA) | United States | $0.626B | 11.54 |
| Performant Healthcare (PHLT) | United States | $0.603B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.586B | 201.00 |
| Nutex Health (NUTX) | United States | $0.498B | 7.54 |
| Omada Health (OMDA) | $0.491B | 0.00 | |
| So-Young (SY) | China | $0.467B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| SBC Medicals (SBC) | United States | $0.460B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.436B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.416B | 0.00 |
| Oncology Institute (TOI) | United States | $0.378B | 0.00 |
| Enhabit (EHAB) | United States | $0.369B | 24.27 |
| Agilon Health (AGL) | United States | $0.358B | 0.00 |
| LifeMD (LFMD) | United States | $0.319B | 0.00 |
| Beauty Health (SKIN) | United States | $0.278B | 0.00 |
| Shoulder Innovations (SI) | $0.185B | 0.00 | |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.141B | 0.00 |
| KindlyMD (NAKA) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.088B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |